Furthermore, evidence for the impact of changes in pathology was derived by the observation that a 75-gene signature that effectively discriminated cancer cells also predicted disease outcomes in primary lung cancer patients, as well as in p53 mutations that influence prognosis. The gene discussed is TP53; the disease is lung carcinoma.